SteelSky Ventures

SteelSky Ventures is a venture capital firm established in 2019 and based in Atlanta, Georgia. The firm specializes in early-stage investments in companies that focus on advancing women's health. SteelSky Ventures is dedicated to supporting high-growth enterprises that enhance access, care, and health outcomes for women. Its investment strategy encompasses various sectors within women's healthcare, including consumer health, digital health, and healthcare infrastructure.

Casey Albert

Managing Partner

Mia Farnham

Principal

Maria Toler

Founding Partner and Managing Partner

Maria Velissaris

Founding and Managing Partner

25 past transactions

Posterity Health

Series A in 2025
Posterity Health is a healthcare company specializing in male reproductive and hormonal health services. It offers telehealth consultations, at-home diagnostic tests, and in-person care for fertility assessments, hormone treatments, and vasectomy procedures. The company aims to enhance access to male fertility specialists and promote awareness of the role of male reproductive health in family planning. Posterity Health supports individuals and couples seeking fertility solutions by providing medical evaluations, treatment options, and educational resources tailored to improve fertility outcomes.

Midi Health

Series B in 2024
Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly those experiencing menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancers, and menstrual problems. Its clinical platform provides personalized treatment protocols crafted by clinicians with expertise in female midlife health. Midi Health utilizes specialized at-home labs, prescription medications, supplements, and lifestyle coaching to support women in managing the challenges they encounter during critical stages of their lives and careers. By focusing on a holistic approach, Midi Health aims to empower women to achieve better health outcomes.

TwentyEight

Seed Round in 2023
TwentyEight Health, Inc. is a Brooklyn-based company founded in 2018 that focuses on providing a digital healthcare platform for women's reproductive and sexual health. The platform offers online doctor evaluations for birth control prescriptions, quick home deliveries of medications, and secure messaging with healthcare professionals. By prioritizing accessibility, TwentyEight Health aims to serve underserved women, particularly Medicaid recipients, and to revolutionize the way they access inclusive and high-quality health services. The company's innovative approach to telemedicine and care coordination facilitates a more convenient and affordable means for women to manage their health needs.

Midi Health

Seed Round in 2022
Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly those experiencing menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancers, and menstrual problems. Its clinical platform provides personalized treatment protocols crafted by clinicians with expertise in female midlife health. Midi Health utilizes specialized at-home labs, prescription medications, supplements, and lifestyle coaching to support women in managing the challenges they encounter during critical stages of their lives and careers. By focusing on a holistic approach, Midi Health aims to empower women to achieve better health outcomes.

Motivo

Series A in 2022
Motivo Consulting, Inc., operating as Motivo, is an online platform that facilitates connections between mental health therapists and clinical supervisors. Founded in 2017 and based in Atlanta, Georgia, Motivo addresses the need for pre-licensed therapists to complete mandatory supervision hours required for licensure. The platform enables users to engage in secure video conferences, allowing therapists to access a broader range of supervisors, thereby overcoming limitations in available options. Additionally, Motivo offers resources such as peer consultations, webinars, and training, enhancing the professional development of its users. With the growth of telehealth services, Motivo has positioned itself as a leader in therapist telesupervision, ensuring that mental health professionals can find appropriate supervision in a convenient and accessible manner.

Moving Analytics

Series A in 2022
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

Huma.AI

Series A in 2022
Huma.AI, Inc. is a technology company based in Palo Alto, California, founded in 2016. It specializes in developing a knowledge automation platform aimed at improving efficiency within the healthcare and pharmaceutical industries. The platform addresses the challenges posed by complex and disparate data systems by connecting various data silos through natural human language. By extracting insights from unstructured data, such as documents and free text, Huma.AI enables users—including companies, scientists, and clinicians—to easily access information and make informed decisions quickly. This innovative approach not only streamlines data access but also allows users to interact with data using everyday language, thereby enhancing the decision-making process in healthcare.

ConcertoCare

Series B in 2022
ConcertoCare is dedicated to delivering primary and complex care to seniors and other adult patients with unmet health and social needs. The company employs a tech-enabled, value-based care model that features three distinct in-home care approaches, all supported by its proprietary population health and analytics platform. ConcertoCare's interdisciplinary teams, led by experienced professionals in home-based geriatric medicine, digital health, palliative care, and healthcare analytics, utilize clinical decision support tools to enhance patient care. This innovative model aims to lower overall healthcare costs while improving health outcomes for its patients.

Bend Health

Seed Round in 2022
Bend Health is a national healthcare company specializing in mental health care for children and adolescents. Founded by experienced professionals from both tech and healthcare sectors, including companies like Oracle and Teladoc Health, Bend Health aims to increase accessibility and reduce costs of expert mental health services. The company offers coaching, therapy, and expedited evaluations with licensed pediatric psychiatry experts through its data-driven technology platform and evidence-based collaborative care model. This approach improves outcomes, reduces stigma, and addresses logistical barriers to mental health care for families.

Proov

Series A in 2021
Proov is a company that specializes in developing rapid response urine test strips for measuring progesterone, a hormone essential for confirming ovulation and supporting conception. Unlike traditional in-home tests that primarily measure hormones like LH, FSH, and estrogen during the early menstrual cycle, Proov's tests provide a more comprehensive assessment by specifically tracking progesterone levels. This capability allows women to not only predict ovulation but also to identify potential hormonal imbalances that may contribute to infertility or miscarriage. By enabling women to monitor their hormonal health at home, Proov offers a cost-effective alternative to fertility clinics and IVF treatments, empowering them to take control of their reproductive health.

Fogarty Institute of Innovation

Series A in 2021
Fogarty Innovation is a nonprofit organization based in Mountain View, California, focused on advancing medical innovation to enhance human health. Founded in 2007, the organization supports promising innovators and researchers by transforming their creative ideas into practical solutions that improve patient care. It operates as an incubator, providing essential funding, mentorship, and research tools to facilitate the development of medical concepts from inception to application. Fogarty Innovation offers two key programs: one aimed at fostering innovation for startups and another dedicated to educating the next generation of inventors. Through these initiatives, Fogarty Innovation coordinates access to vital intellectual, physical, and financial resources to drive medical advancements.

Raydiant Oximetry

Series A in 2021
Raydiant Oximetry, Inc. is a medical device company established in 2015 and headquartered in Mountain View, California. The company specializes in the development of a low-cost, non-invasive device that monitors fetal oxygen levels during labor, with the aim of improving health outcomes for mothers and their babies. By providing real-time data on fetal oxygenation, Raydiant Oximetry's technology seeks to enhance patient care, reduce the occurrence of unnecessary cesarean sections, and lower healthcare costs associated with childbirth. The company's innovations are designed to address potential birth injuries and minimize over-intervention in the delivery process, ultimately striving to improve the overall experience and safety of childbirth.

Mae Health

Seed Round in 2021
Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Cayaba Care

Seed Round in 2021
Cayaba Care is a maternal health company focused on providing comprehensive support to medium and high-risk women throughout their pregnancy and postpartum journeys. The company employs a multidisciplinary approach, utilizing Maternity Navigators who are also certified doulas, to partner with members and enhance birth outcomes. Cayaba Care's services address a range of pregnancy-related concerns, including symptom relief, mental health support, breastfeeding assistance, and postpartum follow-up. By offering both virtual and in-person care, the company aims to alleviate stress and anxiety associated with pregnancy, ensuring that women experience a healthy and safe journey. Cayaba Care collaborates with commercial and Medicaid plans to implement standard and value-based care contracts, ultimately improving care quality and patient experience while achieving significant cost savings.

Ruby Love

Venture Round in 2021
Ruby Love is a women’s apparel company that specializes in innovative undergarments designed to manage leaks and stains associated with menstruation and bladder incontinence. The company offers a range of products, including leak-proof panties, swimsuits for periods, functional undergarments, and period bodysuits. Utilizing proprietary technology, Ruby Love's garments feature built-in absorbent layers that provide comfort and protection by immediately collecting flow, thus preventing leaks and stains. These products allow women to maintain comfort and confidence during their periods and in situations involving stress incontinence or unexpected discharge. Ruby Love aims to enhance women's experiences by providing practical solutions that cater to their unique needs.

Origin

Seed Round in 2021
Origin provides physical therapy services. They focus on pregnancy, postpartum, menopause, and sexual health. They also offer physical therapy for the pelvic floor and the whole body.

TwentyEight

Seed Round in 2020
TwentyEight Health, Inc. is a Brooklyn-based company founded in 2018 that focuses on providing a digital healthcare platform for women's reproductive and sexual health. The platform offers online doctor evaluations for birth control prescriptions, quick home deliveries of medications, and secure messaging with healthcare professionals. By prioritizing accessibility, TwentyEight Health aims to serve underserved women, particularly Medicaid recipients, and to revolutionize the way they access inclusive and high-quality health services. The company's innovative approach to telemedicine and care coordination facilitates a more convenient and affordable means for women to manage their health needs.

Lark

Series C in 2020
Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.

TwentyEight

Venture Round in 2020
TwentyEight Health, Inc. is a Brooklyn-based company founded in 2018 that focuses on providing a digital healthcare platform for women's reproductive and sexual health. The platform offers online doctor evaluations for birth control prescriptions, quick home deliveries of medications, and secure messaging with healthcare professionals. By prioritizing accessibility, TwentyEight Health aims to serve underserved women, particularly Medicaid recipients, and to revolutionize the way they access inclusive and high-quality health services. The company's innovative approach to telemedicine and care coordination facilitates a more convenient and affordable means for women to manage their health needs.

Proov

Seed Round in 2020
Proov is a company that specializes in developing rapid response urine test strips for measuring progesterone, a hormone essential for confirming ovulation and supporting conception. Unlike traditional in-home tests that primarily measure hormones like LH, FSH, and estrogen during the early menstrual cycle, Proov's tests provide a more comprehensive assessment by specifically tracking progesterone levels. This capability allows women to not only predict ovulation but also to identify potential hormonal imbalances that may contribute to infertility or miscarriage. By enabling women to monitor their hormonal health at home, Proov offers a cost-effective alternative to fertility clinics and IVF treatments, empowering them to take control of their reproductive health.

Motivo

Seed Round in 2019
Motivo Consulting, Inc., operating as Motivo, is an online platform that facilitates connections between mental health therapists and clinical supervisors. Founded in 2017 and based in Atlanta, Georgia, Motivo addresses the need for pre-licensed therapists to complete mandatory supervision hours required for licensure. The platform enables users to engage in secure video conferences, allowing therapists to access a broader range of supervisors, thereby overcoming limitations in available options. Additionally, Motivo offers resources such as peer consultations, webinars, and training, enhancing the professional development of its users. With the growth of telehealth services, Motivo has positioned itself as a leader in therapist telesupervision, ensuring that mental health professionals can find appropriate supervision in a convenient and accessible manner.

Mahmee

Seed Round in 2019
Mahmee is an integrated care delivery platform focused on maternal and infant health. It aims to bridge critical gaps in the U.S. healthcare system, which faces high maternity costs and mortality rates, particularly among Black mothers and infants. By providing a digital infrastructure, Mahmee connects patients, independent health professionals, and large healthcare organizations to enhance access to comprehensive prenatal and postpartum care. The platform features a care management system that links health records for mothers and their babies, identifying clinical risks and facilitating collaboration among maternity and infant care practitioners. This enables healthcare providers to share care plans effectively, ensuring coordinated care. Additionally, Mahmee's marketplace allows new and expecting parents to discover community-based perinatal health providers and access care quickly, both in-person and virtually.

TheraB Medical

Seed Round in 2019
TheraB Medical is an early-stage medical device company focused on improving infant healthcare. Its flagship product, the SnugLit™ Portable Phototherapy System, is a wearable, portable solution for treating infant jaundice. Developed in collaboration with over 300 medical professionals and parents, the SnugLit System combines blue light therapy within a swaddle, promoting maternal-infant bonding and breastfeeding while reducing separation stress for both mothers and babies.

Zipline

Series C in 2018
Zipline Inc. is a California-based company that specializes in the design, manufacture, and operation of drones for delivering essential medical supplies. Founded in 2011 and headquartered in Half Moon Bay, the company aims to ensure that every individual has immediate access to vital medical products, including vaccines, medicines, and blood. Zipline operates a sophisticated autonomous logistics network, utilizing proprietary fixed-wing drones to facilitate rapid deliveries to hospitals and health centers, particularly in remote areas. The company not only designs and tests its drones but also assembles the technology that underpins its distribution capabilities, thereby enhancing the efficiency and effectiveness of medical supply delivery.

Joylux

Series A in 2017
Joylux, Inc. is a health and wellness company based in Seattle, Washington, specializing in women's health solutions. Founded in 2013, the company develops LED-focused medical devices aimed at addressing pelvic-floor issues and enhancing vaginal health. Joylux offers an at-home pelvic-floor toning and vaginal rejuvenation device that employs photobiomodulation technology to alleviate symptoms associated with genitourinary syndrome of menopause. The company is dedicated to providing noninvasive, effective, and affordable products that improve various aspects of women's intimate health, while also focusing on collecting health data to help women better predict and manage their symptoms during menopause.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.